Skip to search formSkip to main contentSkip to account menu

Propafenone

Known as: Propafenona, Propafenone [Chemical/Ingredient], 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone 
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
National Institutes of Health

Related topics

Related topics

41 relations
12 HR Propafenone Hydrochloride 225 MG Extended Release Oral CapsuleAmprenavirAtrial FibrillationBradycardia

Narrower (10)

5-hydroxypropafenoneBaxarytmonFenoprainN-depropylpropafenone

Broader (2)

Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.
2001
2001
Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses.
2001
2001
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.
1999
1999
Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
To choose a sensitive protocol to discriminate populations exposed and not exposed to inducers, five urinary metabolite ratios… 
Review
1998
Review
1998
Drug treatment of atrial fibrillation in the managed care era.
1996
1996
Characteristics and management of chaotic atrial tachycardia of infancy.
Review
1994
Review
1994
Management of atrial flutter after the Fontan procedure.
1991
1991
New onset ventricular tachycardia during pregnancy.
Highly Cited
1982
Highly Cited
1982
Suppression of Ventricular Arrhythmias by Propafenone, a New Antiarrhythmic Agent, During Acute Myocardial Infarction in the Conscious Dog A Comparative Study with Lidocaine
The responsiveness of ventricular tachycardia (VT) to propafenone, a new antiarrhythmic agent, was evaluated in the conscious dog… 
Highly Cited
1981
Highly Cited
1981
Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia.
Propafenone is an antiarrhythmic which possesses the properties of a class I agent. Its electrophysiological effects were studied… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)